Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Prevention of Nausea and Vomiting in Stem Cell Transplant
NCT00781768Phase 4Completed
- Sponsor
- Loyola University Chicago
- Start
- Aug 2003
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of aprepitant in nausea ((none)) and Vomiting (2 arms), sponsored by Loyola University Chicago. Primary endpoint: Complete Response Rates Among Standard of Care and Combination Therapy Groups at 14 days. Started Aug 2003; status: completed.
02
Drugs
aprepitant
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT00781768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781768.